Pablo Aispuro-Martin

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Unadjuvanted antenatal pertussis OMV vaccination drives enhanced and durable humoral immunity in offspring.

Unadjuvanted antenatal pertussis OMV vaccination drives enhanced and durable humoral immunity in offspring.

Journal: Frontiers in immunology
Published: May 16, 2026

Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines.

Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines.

Journal: Frontiers in immunology
Published: June 28, 2025

Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response.

Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response.

Journal: Frontiers in immunology
Published: February 17, 2024

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.

Journal: Frontiers in immunology
Published: August 01, 2023

Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.

Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.

Journal: Frontiers in immunology
Published: March 23, 2023

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.

Journal: Frontiers in immunology
Published: August 15, 2022

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.

Journal: Frontiers in immunology
Published: June 24, 2021

Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.

Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.

Journal: Frontiers in medicine
Published: December 11, 2020

Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.

Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.

Journal: Frontiers in microbiology
Published: January 31, 2020

Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection.

Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection.

Journal: Frontiers in immunology
Published: May 03, 2018

Pertussis epidemiology in Argentina: TRENDS after the introduction of maternal immunisation.

Pertussis epidemiology in Argentina: TRENDS after the introduction of maternal immunisation.

Journal: Epidemiology and infection
Published: April 16, 2018

Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.

Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.

Journal: Frontiers in immunology
Published: June 01, 2017
Showing 1-12 of 12

Last Updated: 09/26/2026